Rabbit Polyclonal Neuropilin 1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, African green monkey samples. Cited in 14 publications. Immunogen corresponding to Synthetic Peptide within Human NRP1 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
CD304, NRP, VEGF165R, NRP1, Neuropilin-1, Vascular endothelial cell growth factor 165 receptor
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Neuropilin 1 antibody (AB25998)
ICC/IF image of ab25998 stained SHSY5Y cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab25998, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Neuropilin 1 antibody (AB25998)
IHC image of ab25998 staining in human heart formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab25998, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- WB
Unknown
Western blot - Anti-Neuropilin 1 antibody (AB25998)
All lanes:
Western blot - Anti-Neuropilin 1 antibody (ab25998) at 1/500 dilution
Lane 1:
Untransfected COS-7 cells
Lane 2:
COS-7 cells transfected with HA-tagged Neuropilin 1
Predicted band size: 103 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Neuropilin-1 serves as a co-receptor for both the Vascular Endothelial Growth Factor (VEGF) and Semaphorin family proteins. It plays an important role in processes such as angiogenesis axonal guidance and the immune system. Neuropilin-1 does not function alone; it forms complexes with neuropilin-2 and other receptors like Plexin and VEGFR enhancing signal transduction pathways for angiogenesis and neuronal development. This involvement allows cells to respond appropriately to their environment especially during organismal development and repair processes.
Pathways
Neuropilin-1 facilitates interactions within the VEGF and Semaphorin pathways. In the VEGF pathway Neuropilin-1 enhances binding and signaling efficiency with VEGF closely working alongside VEGFR to promote endothelial cell survival migration and new blood vessel formation. In the Semaphorin pathway Neuropilin-1 interacts with Plexins mediating neuronal pathfinding and axonal growth. These interactions highlight Neuropilin-1's adaptive capabilities in various physiological processes critical for system development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 12:823377 PubMed35600336
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:7261486 PubMed35281516
2022
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed34812142
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:653246 PubMed34150622
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 24:12608-12618 PubMed32951327
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:1321-1334 PubMed32945351
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biochemistry research international 2020:6285987 PubMed32802507
2020
Applications
Unspecified application
Species
Unspecified reactive species
Acta ophthalmologica 98:e1-e12 PubMed31318490
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal 39:6233-6250 PubMed31182634
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 23:125-32 PubMed27033458
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com